Search and Find the CMO / CDMO You Need
Discover highly skilled partners for your drug development and manufacturing project.
These facilities match your main criteria but not every optional filter — including other countries in the same region.

Cenexi
Cenexi
GMP plant on a four-hectare site is located 9 km east of Paris. It is a center of excellence for injectable ampoules.
BATCH SIZE: Small, Medium, Large
CATEGORY / PRODUCT: FDF / DRUG PRODUCTS
MARKETS: EDE (UAE), ANVISA (Brazil), PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)
COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP)
CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGION: Europe
USE: Human, Veterinary
SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
THERAPEUTIC AREAS OF EXPERTISE (ATC): (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Cenexi Hérouville Saint Clair
Cenexi
The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquids.
BATCH SIZE: Small, Medium
CATEGORY / PRODUCT: FDF / DRUG PRODUCTS
COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), FDA (cGMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP)
CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGION: Europe
MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), MHRA (UK)
USE: Human
SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Packaging, Quality Assurance services
THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
PARTICLE ENGINEERING manufacturing site
MAI network supplier
An API and Interemediate manufacturer having global certifications.
Location available after registration
SERVICES manufacturing site
MAI network supplier
R&D and GMP manufacturing site, Bowburn, Durham, UK
Location available after registration
SERVICES manufacturing site
MAI network supplier
R&D Centre
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Location available after registration
CHEMICAL-SYNTHETIC manufacturing site
MAI network supplier
The CDMO company designs, develops, and manufactures new chemical entities to treat human disease.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Production facility that complies with the latest GMP standards for sterile and aseptic liquids, particularly glass ampoules.
Location available after registration
BIOLOGICS manufacturing site
MAI network supplier
Process Development, Gene to Cell Line to GMP to Formulation Development, Analytical Development and Fill-Finish.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
French CDMO key player in drug development and delivery of oral technologies serving the pharma and bio industries.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
CDMO specialized in the manufacture and development of cosmetics,health products, insect repellents, anti-lice / head lice treatments and medical devices.
Location available after registration
CHEMICAL-SYNTHETIC manufacturing site
MAI network supplier
Our 400+ team members in Charles City specialize in late-phase and commercial API development and cGMP manufacturing.
Location available after registration









